This Article Full Text Full Text (PDF) Correction (v114,pe497) All Versions of this Article: 114/5/388    most recent CIRCULATIONAHA.106.632513v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takahashi, T. Articles by Hammond, H. K. Search for Related Content PubMed PubMed Citation Articles by Takahashi, T. Articles by Hammond, H. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL PROPRANOLOL HYDROCHLORIDE Medline Plus Health Information Heart Attack Related Collections Animal models of human disease Heart failure - basic studies Gene therapy Receptor pharmacology Related Article

(Circulation. 2006;114:388-396.)
© 2006 American Heart Association, Inc.

Heart Failure

Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial Infarction

Toshiyuki Takahashi, MD, PhD; Tong Tang, PhD; N. Chin Lai, PhD; David M. Roth, PhD, MD; Brian Rebolledo, BA; Miho Saito, MD; Wilbur Y.W. Lew, MD; Paul Clopton, MS; H. Kirk Hammond, MD

From the Departments of Medicine (T. Takahashi, T. Tang, N.C.L., W.Y.W.L., H.K.H.) and Anesthesiology (D.M.R.), University of California, San Diego, and VA San Diego Healthcare System (T. Takahashi, T. Tang, N.C.L., D.M.R., B.R., M.S., W.Y.W.L., P.C., H.K.H.), San Diego, Calif.

Correspondence to H. Kirk Hammond, MD, VA San Diego Healthcare System (111A), 3350 La Jolla Village Dr, San Diego, CA 92161. E-mail khammond{at}ucsd.edu

Received April 6, 2006; revision received May 23, 2006; accepted May 26, 2006.

Background— Cardiac-directed expression of adenylyl cyclase type VI (AC_VI) in mice results in structurally normal hearts with normal basal heart rate and function but increased responses to catecholamine stimulation. We tested the hypothesis that increased left ventricular (LV) AC_VI content would increase mortality after acute myocardial infarction (MI).

Methods and Results— Transgenic mice with cardiac-directed AC_VI expression and their transgene-negative littermates (control) underwent coronary ligation, and survival, infarct size, and LV size and function were assessed 1 to 7 days after MI. Mice with increased AC_VI expression had increased survival (control 41%, AC_VI 74%; P=0.004). Infarct size and myocardial apoptotic rates were similar in AC_VI and control mice; however, AC_VI mice had less LV dilation (P<0.001) and increased ejection fractions (P<0.03). Three days after MI, studies in isolated perfused hearts showed that basal LV +dP/dt was similar, but graded dobutamine infusion was associated with a more robust LV contractile response in AC_VI mice (P<0.05). Increased LV function was associated with increases in cAMP generation (P=0.0002), phospholamban phosphorylation (P<0.04), sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2a) affinity for calcium (P<0.015), and reduced AV block (P=0.04).

Conclusions— In acute MI, increased cardiac AC_VI content attenuates adverse LV remodeling, preserves LV contractile function, and reduces mortality.

---

 

CLINICAL PERSPECTIVE

Related Article:

Issue Highlights
Circulation 2006 114: 359. [Extract] [Full Text]

This article has been cited by other articles:

				L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney Mouse models of altered protein kinase A signaling Endocr. Relat. Cancer, September 1, 2009; 16(3): 773 - 793. [Abstract] [Full Text] [PDF]

				R. Granata, L. Trovato, M. P. Gallo, S. Destefanis, F. Settanni, F. Scarlatti, A. Brero, R. Ramella, M. Volante, J. Isgaard, et al. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart Cardiovasc Res, July 15, 2009; 83(2): 303 - 312. [Abstract] [Full Text] [PDF]

				M. Gottle, J. Geduhn, B. Konig, A. Gille, K. Hocherl, and R. Seifert Characterization of Mouse Heart Adenylyl Cyclase J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1156 - 1165. [Abstract] [Full Text] [PDF]

				J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]

				P. W. Raake, L. E. Vinge, E. Gao, M. Boucher, G. Rengo, X. Chen, B. R. DeGeorge Jr, S. Matkovich, S. R. Houser, P. Most, et al. G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure Circ. Res., August 15, 2008; 103(4): 413 - 422. [Abstract] [Full Text] [PDF]

				L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF]

				N. C. Lai, T. Tang, M. H. Gao, M. Saito, T. Takahashi, D. M. Roth, and H. K. Hammond Activation of Cardiac Adenylyl Cyclase Expression Increases Function of the Failing Ischemic Heart in Mice J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1490 - 1497. [Abstract] [Full Text] [PDF]

				W. Jiang, S. R. Hall, M. P.W. Moos, R. Y. Cao, S. Ishii, K. O. Ogunyankin, L. G. Melo, and C. D. Funk Endothelial Cysteinyl Leukotriene 2 Receptor Expression Mediates Myocardial Ischemia-Reperfusion Injury Am. J. Pathol., March 1, 2008; 172(3): 592 - 602. [Abstract] [Full Text] [PDF]

				A. Redel, V. Jazbutyte, T. M. Smul, M. Lange, T. Eckle, H. Eltzschig, N. Roewer, and F. Kehl Impact of Ischemia and Reperfusion Times on Myocardial Infarct Size in Mice In Vivo Experimental Biology and Medicine, January 1, 2008; 233(1): 84 - 93. [Abstract] [Full Text] [PDF]

				T. Tang, M. H. Gao, N. C. Lai, A. L. Firth, T. Takahashi, T. Guo, J. X.-J. Yuan, D. M. Roth, and H. K. Hammond Adenylyl Cyclase Type 6 Deletion Decreases Left Ventricular Function via Impaired Calcium Handling Circulation, January 1, 2008; 117(1): 61 - 69. [Abstract] [Full Text] [PDF]

				S. Okumura, D. E. Vatner, R. Kurotani, Y. Bai, S. Gao, Z. Yuan, K. Iwatsubo, C. Ulucan, J.-i. Kawabe, K. Ghosh, et al. Disruption of Type 5 Adenylyl Cyclase Enhances Desensitization of Cyclic Adenosine Monophosphate Signal and Increases Akt Signal With Chronic Catecholamine Stress Circulation, October 16, 2007; 116(16): 1776 - 1783. [Abstract] [Full Text] [PDF]

				K. Leineweber, M. Bohm, and G. Heusch Cyclic Adenosine Monophosphate in Acute Myocardial Infarction With Heart Failure: Slayer or Savior? Circulation, August 1, 2006; 114(5): 365 - 367. [Full Text] [PDF]